IART FY 2022 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.6B+1.0% YoY

Gross Profit

$970M62.3% margin

Operating Income

$239M15.3% margin

Net Income

$181M11.6% margin

EPS (Diluted)

$2.16

Cash Flow

Operating Cash Flow

$264M

Free Cash Flow

$217M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$3.9B

Total Liabilities

$2.1B

Stockholders' Equity

$1.8B

Cash & Equivalents

$457M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.5B	+1.0%
Gross Profit	$970M	$945M	+2.7%
Operating Income	$239M	$197M	+21.1%
Net Income	$181M	$169M	+6.8%